Okklo life sciences BV is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies. The current programs are focussed on lysosomal storage disorders and cardiovascular disorders. The company was founded in December 2011 by a group of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product. We are continuously looking for collaborations and partnering opportunities with public and private partners - please visit our website to learn more about our technology platform strategy and development pipeline.
View Top Employees from Okklo Life Sciences| Website | http://www.okklo.com |
| Revenue | $5 million |
| Employees | 4 (0 on RocketReach) |
| Founded | 2011 |
| Address | 5 Transistorweg, Nijmegen, Gelderland, NL |
| Phone | +31 6 10489150 |
| Technologies |
JavaScript,
HTML,
PHP
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Business Services General, Business Services |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies |
Looking for a particular Okklo Life Sciences employee's phone or email?
Okklo Life Sciences Questions
The Okklo Life Sciences annual revenue was $5 million in 2023.
Okklo Life Sciences is based in Nijmegen, Gelderland.
The NAICS codes for Okklo Life Sciences are [5417, 54, 541, 541713, 54171].
The SIC codes for Okklo Life Sciences are [873, 87].
Related Companies
